Skip to main content
. Author manuscript; available in PMC: 2015 Oct 23.
Published in final edited form as: Diabetes Care. 2008 Feb 19;31(5):910–915. doi: 10.2337/dc07-1687

Figure 1.

Figure 1

Associations of CRP polymorphisms (A) and haplotypes (B) with baseline plasma CRP levels (geometric means ± 95% CI). P values were obtained from the generalized estimating equation model adjusting for age, sex, BMI, plasma triglyceride and interleukin-6, smoking status, alcohol consumption, physical activity, and hormones. Further adjustment for use of aspirin and nonsteroidal anti-inflammatory drugs and drugs for lowering cholesterol, diabetes, and hypertension did not modify the statistical significance. *P < 0.05 and †P < 0.001 compared with haplotype 1112.